NCT01233245View on ClinicalTrials.gov

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

CompletedOBSERVATIONAL
Enrollment

1,077

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Relapsing Remitting MS (RRMS)Secondary Progressive MS (SPMS)
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

250 µg, sub-cutaneously, on alternate days

Trial Locations (15)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY